<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 09 Feb 2026 07:28:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
  <item>
   <title>Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;TORONTO, Feb.  09, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=3uwbThL989jZPiOPWCjB67iDOE854GRUmUk5iYOnSZlnPnYIdcLXE7By3qJDi0cK4N2e7Z96NUUpyoosAd43oh4VuXPIY5H86fiiqUuQ7mw=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Arch Biopartners Inc&lt;/a&gt;. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the University of Calgary has published new data in the peer-reviewed journal &lt;em&gt;Inflammation Research&lt;/em&gt; identifying interleukin-32 (IL-32) as a novel lipid droplet-associated cytokine that may contribute to tubular injury and inflammation in diabetic kidney disease (DKD).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The newly published findings, based on human kidney tissue, show that during DKD, kidney cells accumulate lipid (fat) droplets that are coated with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Arch+Biopartners+Scientists+Publish+New+Data+Linking+the+Cytokine+IL-32+to+Inflammation+and+Diabetic+Kidney+Disease/25964807.html</guid>
   <pubDate>Mon, 09 Feb 2026 07:28:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.10984556</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33840901</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.36078215</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42382650</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ACHFF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARCH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01688245</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02555813</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03302156</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.16433397</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49223069</category>
   	  </item>
 </channel>
</rss>
